Tumorigenesis, diagnosis, and therapeutic potential of exosomes in liver cancer
Open accessThe DOI matches its Crossref record; 223 of the 223 references it cites were found in a registry or an index.
Abstract
Hepatocellular carcinoma (HCC, also called primary liver cancer) is one of the most fatal cancers in the world. Due to the insidiousness of the onset of HCC and the lack of effective treatment methods, the prognosis of HCC is extremely poor, and the 5-year average survival rate is less than 10%. Exosomes are nano-sized microvesicle and contain various components such as nucleic acids, proteins, and lipids. Exosomes are important carriers for signal transmission or transportation of material from cell to cell or between cells and tissues. In recent years, exosomes have been considered as potential therapeutic targets of HCC. A large number of reports indicate that exosomes play a key role in the establishment of an HCC microenvironment, as well as the development, progression, invasion, metastasis, and even the diagnosis, treatment, and prognosis of HCC. However, the exact molecular mechanisms and roles of exosomes in these processes remain unclear. We believe that elucidation of the regulatory mechanism of HCC-related exosomes and its signaling pathway and analysis of its clinical applications in the diagnosis and treatment of HCC can provide useful clues for future treatment regimens for HCC. This article discusses and summarizes the research progress of HCC-related exosomes and their potential clinical applications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
Items 201–223 of 223
MiR-125b attenuates human hepatocellular carcinoma malignancy through targeting SIRT6.
Shi, S., Yang, Y., Liu, M., Liu, B., Yang, X. P., Yu, M., Qi, H., Ren, M., Wang, Z., Zou, J., et al. (2018) · Europe PMC (PubMed Central) · Cited by 49
The functional role of exosome in hepatocellular carcinoma
Liu, H., & Li, B. (2018) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-018-2712-7 · Cited by 46
Recent progress in the emerging role of exosome in hepatocellular carcinoma
Abudoureyimu, M., Zhou, H., Zhi, Y., Wang, T., Feng, B. C., Wang, R., & Chu, X. (2018) · Cell Proliferation · doi:10.1111/cpr.12541 · Cited by 43
Synaptotagmin‐like protein 4 and Rab8 interact and increase dense granule release in platelets
HAMPSON, A., O'CONNOR, A., & Smolenski, A. (2012) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12068 · Cited by 39
Li, F., Qiao, C., Gao, S., Fan, Y., Chen, L.-Y., & Wang, K. (2018) · Free Radical Research · doi:10.1080/10715762.2018.1443448 · Cited by 39
Zaja, R., Caminada, D., Lončar, J., Fent, K., & Smital, T. (2008) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2007.11.001 · Cited by 34
He, X., Li, J., Guo, W., Liu, W., Yu, J., Song, W., Dong, L., Wang, F., Yu, S., Zheng, Y., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2955 · Cited by 33
Ma, B., Jiang, H., Jia, J., Di, L., Song, G., Yu, J., Zhu, Y., Lü, Z., Wang, X., Zhou, X., et al. (2012) · Clinical & Translational Oncology · doi:10.1007/s12094-012-0860-9 · Cited by 33
Plasma Cell-Free DNA as a Predictive Marker after Radiotherapy for Hepatocellular Carcinoma
Park, S. J., Lee, E., Rim, C. H., & Seong, J. (2018) · Yonsei Medical Journal · doi:10.3349/ymj.2018.59.4.470 · Cited by 33
Zhong, Y., Li, Y., Song, T., & Zhang, D. (2019) · Physiological Genomics · doi:10.1152/physiolgenomics.00019.2019 · Cited by 33
Huang, G., & Brigstock, D. R. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01072.x · Cited by 31
Identification of the novel 3′ UTR sequences of human IL-21 mRNA as potential targets of miRNAs
Enomoto, Y., Takagi, R., Naito, Y., Kiniwa, T., Tanaka, Y., Hamada‐Tsutsumi, S., Kawano, M., Matsushita, S., Ochiya, T., & Miyajima, A. (2017) · Scientific Reports · doi:10.1038/s41598-017-07853-x · Cited by 31
Modifying exosome release in cancer therapy: How can it help?
Moloudizargari, M., Asghari, M. H., & Abdollahi, M. R. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.07.001 · Cited by 30
Žíla, V., Difato, F., Klimova, L., Huérfano, S., & Forstová, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096922 · Cited by 29
Weeraphan, C., Phongdara, A., Chaiyawat, P., Diskul‐Na‐Ayudthaya, P., Chokchaichamnankit, D., Verathamjamras, C., Netsirisawan, P., Yingchutrakul, Y., Roytrakul, S., Champattanachai, V., et al. (2019) · PROTEOMICS · doi:10.1002/pmic.201800159 · Cited by 26
Structural Determinants Allowing Endolysosomal Sorting and Degradation of Endosomal GTPases
Valero, R. A., Oeste, C. L., Stamatakis, K., Ramos, I., Herrera, M., Boya, P., & Pérez‐Sala, D. (2010) · Traffic · doi:10.1111/j.1600-0854.2010.01091.x · Cited by 24
Choi, S. H., Park, J. Y., Kang, W., Kim, S. U., Kim, D. Y., Ahn, S. H., Ro, S. W., & Han, K. (2015) · APOPTOSIS · doi:10.1007/s10495-015-1185-2 · Cited by 23
Sun, F. Z., Wang, J., Luo, J.-J., Wang, Y.-Q., & Pan, Q. (2018) · BioMed Research International · doi:10.1155/2018/2747461 · Cited by 21
Role of transferrin receptor 2 in hepatic accumulation of iron in patients with chronic hepatitis C
Mifuji, R., Kobayashi, Y., Ma, N., QIANG, Q. L., Urawa, N., Horiike, S., Iwasa, M., Kaito, M., Malavasi, F., & Adachi, Y. (2006) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2005.04151.x · Cited by 20
Schattenberg, J. M., & Lee, M. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.064 · Cited by 19
Splicing variant of hepcidin mRNA
Sasaki, K., Kohgo, Y., & Ohtake, T. (2019) · Vitamins and hormones · doi:10.1016/bs.vh.2019.01.006 · Cited by 12
Exophilin-5 Supports Lysosome-Mediated Trafficking Required for Epidermal Differentiation
Monteleon, C. L., Lee, I., & Ridky, T. W. (2019) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2019.04.014 · Cited by 8
A Cell-Free Content Mixing Assay for SNARE-Mediated Multivesicular Body-Vacuole Membrane Fusion
Karim, M. A., Samyn, D. R., & Brett, C. L. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8760-3_19 · Cited by 3
Cited by
Exosomes: key players in cancer and potential therapeutic strategy
Dai, J., Su, Y., Zhong, S., Cong, L., Liu, B., Yang, J., Tao, Y., He, Z., Chen, C., & Jiang, Y. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00261-0 · Cited by 1,186
Current Strategies for Exosome Cargo Loading and Targeting Delivery
Zeng, H., Guo, S., Ren, X., Wu, Z., Liu, S., & Yao, X. (2023) · Cells · doi:10.3390/cells12101416 · Cited by 424
The role of FGF21 and its analogs on liver associated diseases
Falamarzi, K., Malekpour, M., Tafti, M. F., Azarpira, N., Behboodi, M., & Zarei, M. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.967375 · Cited by 94
Ma, J., Li, Y., Chen, M., Wang, W., Zhao, Q., He, B., Zhang, M., & Jiang, Y. (2023) · Cell Biology and Toxicology · doi:10.1007/s10565-022-09714-4 · Cited by 37
Metadata
- Authors
- Wang, H., Lu, Z., & Zhao, X.
- Venue
- Journal of Hematology & Oncology
- Published
- 2019-12
- Volume
- 12
- Issue
- 1
- Pages
- 133-133
- ISSN
- 1756-8722 (ISSN-L)
- OpenAlex
- W2994995839
- Cited by
- 262
- References
- 223
- FWCI
- 9.45
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.